EDSA
Edesa Biotech, Inc. Common Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
EDSA Stock Analysis: Buy, Sell, or Hold?
$2.08
-0.14 (-6.31%)
▼
5d:
-2.35%
30d:
-21.51%
90d:
-61.12%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
50/100
Position
OVERSOLD
30-Day Fair Range
$2.22 – $3.28
Position: OVERSOLD
Forward P/E & Valuation
-1.0x
Next 12M consensus est.
Wall Street Target
$16.33
+685.3% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.85 / $3.93
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: EDSA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When EDSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: EDSA is currently trading at $2.08, which is considered oversold relative to its 30-day fair value range of $2.22 to $3.28.
Technical Outlook: Technically, EDSA is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $3.93. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.33 (+685.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EDSA is in a strong downtrend. Immediate support is located at $1.85, while resistance sits at $3.93. Short-term momentum is weak, with the stock down 6.3% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $16.33 (+685.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.22 -
$3.28
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Trading Range & Key Levels
30-Day Trading Range
$2.22 -
$3.28
Current vs Trading Range
OVERSOLD
Support Level
$1.85
Resistance Level
$3.93
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BEARISH: Downward momentum (-6.3%)
- BULLISH: Trading 685.3% below Wall St target ($16.33)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.01
Wall Street Target
$16.33
(+685.3%)
Revenue Growth (YoY)
-99.9%
Share EDSA Analysis
Share this live EDSA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EDSA)
Bullish
5 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
4 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
EDSA stock is generating bullish sentiment on StockTwits with no new news articles available.
Key Retail Themes:
Bullish sentiment towards $EDSA
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:42 PM ET
Data refreshes hourly during market hours. Next update: 8:42 PM
Data refreshes hourly during market hours. Next update: 8:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EDSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EDSA Research Pages
